Kevin D. Kee,Ernest D. Penachio,Abhijit Kamerhar,Michael M. Lipp,Richard P. Batycky
申请号：
US14174179
公开号：
US20140220119A1
申请日:
2014.02.06
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L. The invention further provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L wherein the capsule material comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide.
